Mr Gerald E Gavlak, PA | |
5001 Transportation Dr Ste 101, Sheffield Village, OH 44054-2850 | |
(440) 329-2800 | |
(440) 329-2810 |
Full Name | Mr Gerald E Gavlak |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Experience | 23 Years |
Location | 5001 Transportation Dr Ste 101, Sheffield Village, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003929381 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | PA9102311 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Hospitals - Elyria Medical Center | Elyria, OH | Hospital |
Mercy Regional Medical Center | Lorain, OH | Hospital |
Uh St John Medical Center | Westlake, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
The Director of the Pan American Health Organization (PAHO), Dr. Mirta Roses, and the Permanent Representative of Canada to the Organization of American States (OAS), Ambassador Graeme C. Clark, have signed a master framework document that represents an important step forward in the strategic relationship between PAHO and the Canadian government Ambassador Graeme C. Clark and Dr. Mirta Roses sign the strategic cooperation framework.
A Veterans Affairs study of nearly 1,700 hernia-repair operations found fewer recurrences and complications overall with open surgery than with laparoscopic surgery. The study is being presented April 25 at the spring meeting of the American College of Surgeons in Boston. The findings also appear in the April 29 issue of the New England Journal of Medicine.
Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.
Gilead Sciences, Inc. today announced new data from the open-label phase of two pivotal Phase III clinical trials (Studies 102 and 103) evaluating the four-year efficacy of Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B virus (HBV) infection.
As previously disclosed, Albany Molecular Research, Inc. ("AMRI" or "the "Company") (NASDAQ: AMRI) received a warning letter, dated August 17, 2010, from the U.S. Food and Drug Administration (FDA) in connection with the FDA's inspection of the Company's pharmaceutical manufacturing facility located in Burlington, Massachusetts.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Gerald E Gavlak, PA 5001 Transportation Dr Ste 101, Sheffield Village, OH 44054-2850 Ph: (440) 329-2800 | Mr Gerald E Gavlak, PA 5001 Transportation Dr Ste 101, Sheffield Village, OH 44054-2850 Ph: (440) 329-2800 |
News Archive
The Director of the Pan American Health Organization (PAHO), Dr. Mirta Roses, and the Permanent Representative of Canada to the Organization of American States (OAS), Ambassador Graeme C. Clark, have signed a master framework document that represents an important step forward in the strategic relationship between PAHO and the Canadian government Ambassador Graeme C. Clark and Dr. Mirta Roses sign the strategic cooperation framework.
A Veterans Affairs study of nearly 1,700 hernia-repair operations found fewer recurrences and complications overall with open surgery than with laparoscopic surgery. The study is being presented April 25 at the spring meeting of the American College of Surgeons in Boston. The findings also appear in the April 29 issue of the New England Journal of Medicine.
Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.
Gilead Sciences, Inc. today announced new data from the open-label phase of two pivotal Phase III clinical trials (Studies 102 and 103) evaluating the four-year efficacy of Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B virus (HBV) infection.
As previously disclosed, Albany Molecular Research, Inc. ("AMRI" or "the "Company") (NASDAQ: AMRI) received a warning letter, dated August 17, 2010, from the U.S. Food and Drug Administration (FDA) in connection with the FDA's inspection of the Company's pharmaceutical manufacturing facility located in Burlington, Massachusetts.
› Verified 7 days ago
Kaitlin Maloney, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5001 Transportation Dr, Sheffield Village, OH 44054 Phone: 440-329-2800 | |
Eric Gaines, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5001 Transportation Dr, Sheffield Village, OH 44054 Phone: 440-329-2800 Fax: 440-329-2810 | |
Vanessa R Kabat, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5001 Transportation Dr Ste 101, Sheffield Village, OH 44054 Phone: 440-329-2800 Fax: 440-329-2810 | |
Megan Henfling, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5334 Meadow Lane Ct, Sheffield Village, OH 44035 Phone: 440-934-5454 | |
Amy Ann Bradbury, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5334 Meadow Lane Ct, Sheffield Village, OH 44035 Phone: 440-934-5454 Fax: 440-934-8999 | |
Mr. Robert Harasty, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5001 Transportation Dr, Sheffield Village, OH 44054 Phone: 440-329-2800 |